Psychiatry & Neurology Doctors in Goleta, CA Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Denis Franklin, M.D. Psychiatry & Neurology - Forensic Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5662 Calle Real, Box #150, Goleta, CA 93117 Phone: 707-291-2200

Dr. Carmen Veiga Zuk, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 7620 Hollister Ave, Unit #219, Goleta, CA 93117 Phone: 805-968-5319    Fax: 805-968-5319

Dr. Robert M Nagy, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5951 Encina Rd, Suite #200, Goleta, CA 93117 Phone: 805-681-0520    Fax: 805-681-0524

Ian Matthew Jones, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5662 Calle Real # 125, Goleta, CA 93117 Phone: 415-669-4265

Dr. Yvonne Beth Ferguson, MD, MPH Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5951 Encina Rd, Goleta, CA 93117 Phone: 805-967-6967    Fax: 805-681-0524

Pamela Reeves, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5951 Encina Rd Ste 103, Goleta, CA 93117 Phone: 805-681-8480    Fax: 805-681-8581

Dr. Michael Mcvea Ferguson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 5901 Encina Rd, Suite A, Goleta, CA 93117 Phone: 805-205-0032    Fax: 866-769-1797

News Archive

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Revolutions Medical Corporation announced today that due to the launch of its 3ml RevVac Safety SyringeTM during the Medica show in Dusseldorf, Germany and the enormous interest that the launch has received from healthcare professionals and corporations in Europe, the company will host an additional reception in London on Saturday, November 20th from 7:30 PM - 9:30 PM at the Landmark Hotel, Tower Suite.

World Heart's Levacor VAD implant performed at INTEGRIS Baptist Medical Center

World Heart Corporation ("WorldHeart"), a developer of mechanical circulatory systems, announced today that the first U.S. implant of the Levacor Ventricular Assist Device ("VAD") was successfully performed at INTEGRIS Baptist Medical Center ("INTEGRIS") in Oklahoma City on Wednesday, January 13, 2010.

Targeting CXCR4–CXCL12–CXCR7 axis combats mTOR inhibitor resistance in renal cancer

There is considerable crosstalk between the CXCR4–CXCL12–CXCR7 axis and the mammalian target of rapamycin pathway in human renal cell carcinoma, and targeting the axis may overcome drug resistance to mTOR inhibitors, researchers suggest.

OraSure granted FDA approval for final phase studies of OraQuick Rapid HIV-1/2 Antibody Test

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced that the U.S. Food and Drug Administration ("FDA") has granted an investigational device exemption (IDE) for the Company to conduct the final phase of clinical testing for FDA approval of its OraQuick® Rapid HIV-1/2 Antibody Test for sale in the consumer or over-the-counter ("OTC") market.

Hormone found naturally in the body has the ability to cause limited weight loss

Research at the Oregon National Primate Research Center (ONPRC) at Oregon Health & Science University has demonstrated that a hormone found naturally in the body has the ability to cause limited weight loss. Specifically, the research revealed that peptide YY (PYY) can reduce food consumption in the morning, leading to a mild level of weight loss in the short term.

Read more Medical News

› Verified 4 days ago